Daniel Contreras on 10th Jun

LONDON – The more creative you are, the more chances of suffering from schizophrenia and bipolar disorder – revealed...

Daniel Contreras on 10th Jun

Alirocumab, also known as Praluent has been approved by advisers for the Food and Drug Administration (FDA) as the most promising...

Daniel Contreras on 09th Jun

Cambridge, MA. – Sage Therapeutics, a small biotech company from Cambridge may have a potential cure for postpartum...

Amgen's High LDL Cholesterol Drug Repatha
Daniel Contreras on 09th Jun

On Monday, the FDA released its review of a new Amgen cholesterol drug ahead of a meeting on Wednesday to consider the drug’s...

Adam Kreller on 08th Jun

SF. – Team of doctors at two hospitals, UCSF and California Pacific Medical Center in San Francisco performed 18 surgeries,...

Daniel Contreras on 07th Jun

HAMDEN, Conn. – A study that’s equal parts icky and disconcerting indicates toothbrushes in communal bathrooms may...

Daniel Contreras on 06th Jun

On Saturday, South Korea confirmed nine more cases of Middle East Respiratory Syndrome (MERS), bringing the total number...

Daniel Contreras on 04th Jun

Research scientists at Massachusetts General Hospital have taken a huge step forward in medical science, as they’ve...

Daniel Contreras on 03rd Jun

A new study finds that teenagers are going straight to the Internet for any health concerns they have. The study, presented...

Daniel Contreras on 03rd Jun

A drug trial of a new immunotherapy combination shows improvement in reducing the rate of deaths and progression than the...